| Bioactivity | FA-Ala-Arg is a dipeptide with furylacryloyl group. FA-Ala-Arg breaks down to produce arginine. While cell-surface Carboxypeptidase-D (CPD) also increases intracellular Arg, which is converted to nitric oxide (NO). FA-Ala-Arg enhances NO production in MCF-7 cells. FA-Ala-Arg also increases the cell survival of prolactin (PRL)-treated cells, PRL regulates CPD mRNA levels in cells[1]. |
| Name | FA-Ala-Arg |
| CAS | 76079-06-6 |
| Sequence | {FA}-Ala-Arg |
| Shortening | {FA}-AR |
| Formula | C16H23N5O5 |
| Molar Mass | 365.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Abdelmagid SA, et al. Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells. Endocrinology. 2008 Oct;149(10):4821-8. |
FA-Ala-Arg
CAS: 76079-06-6 F: C16H23N5O5 W: 365.38
FA-Ala-Arg is a dipeptide with furylacryloyl group. FA-Ala-Arg breaks down to produce arginine. While cell-surface Carbo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.